Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Male or infertile female subjects who are between 18-55 years old (inclusive)
Be between 18 and 65 years old
Must not have
History of tuberculosis or current active/latent infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial is testing different doses of ICP-332 in healthy volunteers to see how the drug behaves in the body when given multiple times.
Who is the study for?
This trial is for healthy individuals who meet specific health criteria. The exact inclusion and exclusion details are not provided, but typically participants should have no significant medical conditions and be within a certain age range.
What is being tested?
The study is testing ICP-332 tablets against placebo tablets to see how they're tolerated in the body and what effects they have. It's a phase I trial, which means it's an early-stage study focusing on safety.
What are the potential side effects?
Since this is a phase I trial of ICP-332 in healthy subjects, potential side effects are unknown at this stage. They will be closely monitored for any adverse reactions compared to those taking the placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a man or a woman unable to have children, aged 18 to 55.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had tuberculosis or currently have an active or latent infection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ICP-332Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
InnoCare Pharma Inc.Lead Sponsor
4 Previous Clinical Trials
600 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger